Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Broken-wall reishi spore triterpenes (ganoderic acids)

Reishi Mushroom Triterpenes (Ganoderic Acids) · also known as Ganoderic acid, Broken-wall reishi spore oil, Reishi triterpenes, Ganoderma lucidum

Reishi triterpenes are fat-soluble tetracyclic triterpenoids found in reishi. In-vitro experiments show that some ganoderic acids can inhibit histamine release, and animal studies suggest they can affect antioxidant signaling in the liver. Human evidence for pure triterpenes is still insufficient.

Typical dose: Standardized reishi triterpenes 300–1000 mg/day, or reishi spore oil 500–1000 mg/day, taken with a meal. This dose is not well supported by human evidence, and the content of spore oil and triterpene extracts is not interchangeable.
Absorption and forms: Water extracts of the reishi fruiting body are rich in polysaccharides, while alcohol extracts and supercritical CO2 extracts of broken-wall spores are enriched in fat-soluble ganoderic acids. Data on gut absorption of triterpenes are limited. They are commonly taken with a meal that contains fat, but no human study has measured how efficiently they are absorbed.

Clinical uses and human evidence

High triglycerides

BeneficialGrade C · Preliminary evidence
Studies (1)
  1. Wang 2025 · Nutrients · RCT · n=113 — Clinical Evaluation of Ganoderma lucidum Spore Oil for Triglyceride Reduction: A Randomized, Double-Blind, Crossover Study

High LDL cholesterol

BeneficialGrade C · Preliminary evidence
Studies (1)
  1. Wang 2025 · Nutrients · RCT · n=113 — Clinical Evaluation of Ganoderma lucidum Spore Oil for Triglyceride Reduction: A Randomized, Double-Blind, Crossover Study

Fatigue and energy

BeneficialGrade C · Preliminary evidence
Studies (1)
  1. Zhao 2012 · Evid Based Complement Alternat Med · RCT · n=48 — Spore Powder of Ganoderma lucidum Improves Cancer-Related Fatigue in Breast Cancer Patients Undergoing Endocrine Therapy: A Pilot Clinical Trial

Age-related cognitive decline

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Wang 2018 · Medicine (Baltimore) · RCT · n=42 — Spore powder of Ganoderma lucidum for the treatment of Alzheimer disease: A pilot study

Blood sugar and insulin resistance

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Klupp 2015 · Cochrane Database Syst Rev · Systematic review — Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors

Mechanisms of action

Nrf2/ARE activation of endogenous antioxidant enzymes

★★☆☆☆Mechanism evidence: grade CSecondary target

In mouse models, some ganoderic acids can affect Nrf2 and HO-1 markers in the liver. No human study has yet measured specific markers such as NQO1 and HO-1 after oral reishi triterpenes, so the liver-protective findings cannot be applied directly to humans.

References (1)
  1. Sun 2021 · Mouse study: some ganoderic acids affected liver Nrf2/HO-1-related markers

Mast cell membrane stabilization and degranulation blockade

★★☆☆☆Mechanism evidence: grade DPrimary target

In isolated rat mast cells, some purified ganoderic acids can inhibit histamine release. This result comes from an isolated-cell system. There is no evidence on whether usual doses of spore oil reach comparable concentrations in humans and inhibit degranulation.

References (1)
  1. Kohda 1985 · Isolated rat mast cell study: some purified ganoderic acids can inhibit histamine release

Pattern recognition receptor (PRR) immune surveillance and trained immunity

★☆☆☆☆Mechanism evidence: grade DSecondary target

Evidence that reishi triterpenes activate Dectin-1 or TLRs is insufficient, and changes in immune cells and interferon markers cannot be attributed to the triterpenes. The relevant receptor studies mainly address reishi polysaccharides or fungal β-glucans. No reliable study has yet shown that oral pure triterpenes induce trained immunity.

References (1)
  1. 2010 study · Human macrophage study: fungal β-glucans can activate immune cells through Dectin-1/Syk signaling, but this cannot be directly attributed to reishi triterpenes

Safety and drug interactions

Contraindicated in people taking immunosuppressants after an organ transplant. Stopping 1 week before surgery is advised, because it may mildly inhibit platelet aggregation. There are case reports of liver injury linked to reishi products, although the causal link and the responsible ingredients are still uncertain. If liver function tests become abnormal, stop taking it and see a doctor.

Additive bleeding risk

Can inhibit platelet aggregation. Each of these has a mild antiplatelet or fibrinolytic effect. Alone, the effect is usually small, but when several are combined, the tendency to bleed becomes more noticeable. Stop them 1–2 weeks before surgery or a tooth extraction, and watch for gum bleeding or more bruising.

Added liver burden

Case reports of liver injury with reishi powder. Each of these has case reports of liver injury. If several are taken together long term, have liver function checked regularly. Stop them right away and see a doctor if you develop fatigue, poor appetite, yellowing of the skin or whites of the eyes, or darker urine.

Immune stimulation

Has immunomodulating effects. Each of these stimulates immune responses. They may counteract immunosuppressant drugs, and caution is also needed during active autoimmune disease.

Open in the interactive app ›